Citazione APA

MURAKAMI, T., MURATA, T., KAWAGUCHI, K., KIYUNA, T., IGARASHI, K., HWANG, H. K., . . . HOFFMAN, R. M. (2017). Cervical Cancer Patient-Derived Orthotopic Xenograft (PDOX) Is Sensitive to Cisplatinum and Resistant to Nab-paclitaxel. Anticancer Res.

Stile di citazione Chicago

MURAKAMI, TAKASHI, et al. "Cervical Cancer Patient-Derived Orthotopic Xenograft (PDOX) Is Sensitive to Cisplatinum and Resistant to Nab-paclitaxel." Anticancer Res 2017.

Citazione MLA

MURAKAMI, TAKASHI, et al. "Cervical Cancer Patient-Derived Orthotopic Xenograft (PDOX) Is Sensitive to Cisplatinum and Resistant to Nab-paclitaxel." Anticancer Res 2017.

Attenzione: Queste citazioni potrebbero non essere precise al 100%.